Medical device makers need to comply with new EU directive soon

  
EU reaffirms medical device directive deadline of 2010. Source: Delegation of the European Commission 
The European Union’s (EU) revised Medical Devices Directive will go into effect in less than two years, and manufacturers that do not take advance steps to comply with it may face unnecessary delays in certification — or even lose certification.

However, many manufacturers do not seem to be taking the necessary steps to meet the March 2010 deadline, Claire McKenna, medical device program manager with the National Standards Authority of Ireland, told FDA News.

“I suppose the first thing we’ve noticed is people aren’t asking any questions because they don’t seem to be aware of it,” McKenna said. “Either they don’t know about it or they think it’s way down the road.”

The biggest change in the directive deals with clinical evaluations. Currently, companies can reference testing data for similar devices when applying for certification. But in 2010, the “literature comparison route” will require exact device comparisons, McKenna said.

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.